Phase 1 Osteoarthritis Trial, Recruiting NCT07351968 Sponsor: Shandong Suncadia Medicine Co., Ltd. Condition: Osteoarthritis
Back to Osteoarthritis

Phase 1 Osteoarthritis Trial, Recruiting

NCT07351968
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to sign a consent form before any trial activities begin
  • People who rate their knee pain at 4 or higher on a numbered pain scale (0–10) at their first screening appointment
  • People who are willing to stop all other medical and non-medical treatments for their knee pain during the study, except for paracetamol (acetaminophen) as a rescue medication
  • People of childbearing potential who agree to use highly effective contraception with their partner from the time of signing the consent form until one month after the last dose of the trial medication

Who may not be able to join:

  • People who have a history of other conditions affecting the knee joint being studied
  • People who have had a major injury or surgery to their knee or hip joint in the past year
  • People who are planning to have any surgical procedure during the study period
  • People who have mostly or completely lost the ability to move around
  • People who have other health conditions that could make it difficult to assess knee pain accurately
  • People who have a neuropsychiatric (mental health or neurological) condition that the trial doctor believes could affect pain assessments or self-reported scores
  • People who have serious or poorly controlled ongoing health conditions
  • People who have had a clinically confirmed history of peptic ulcer, bleeding, perforation, or bowel obstruction within the past year
  • People who currently require medication or surgery for a relevant condition (confirm with trial site)
  • People who have had a diagnosis of a malignant tumour (cancer) within the past 5 years
  • People who have a history of drug misuse or heavy alcohol use within the past 2 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86-0518-82342973

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Registry
ClinicalTrials.gov
Start date
10 March 2026
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change from baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale scores.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov